Menu

Prominent Cell Biologist Fired After Data Manipulation Investigation

The University of Tokyo confirmed last August that Yoshinori Watanabe tampered with research-related images, and dismissed him in late April.

Apr 30, 2018
Shawna Williams

FLICKR, CHAO-WEI JUANA University of Tokyo scientist known for his work on cell division has been fired, Retraction Watch reports. The university announced the “disciplinary dismissal” in a statement released on April 27.

The university began investigating Yoshinori Watanabe in August 2016 and released its findings a year later. According to an August 2017 article in Science, the investigating committee found five papers in which Watanabe’s group had falsified images and graphs. Of the affected papers, two appeared in Nature, two in Science, and one in EMBO Reports. (One of the Science publications has since been retracted.) But the committee recommended that disciplinary actions not be taken until it had completed its review of other papers.

See “Investigation Finds Cell Biologist Guilty of Misconduct

Reporting on the same committee findings, Nature noted at the time that image enhancement was commonplace in Watanabe’s lab and that he taught trainees how to make the alterations. All of the members of the lab had already left before the findings were released, according to the publication, and a major research grant to Watanabe had been suspended.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.